PMLRARA Quantitative Test
Are you concerned about acute promyelocytic leukemia (APL)? DNA Labs UAE offers the PMLRARA Quantitative Test to detect the presence of the PML/RARA fusion gene, a genetic abnormality associated with APL.
Test Details
The PML/RARA quantitative test is a laboratory test performed on a sample of bone marrow or blood cells. Using the Real Time PCR method, this test amplifies and detects the PML/RARA fusion gene. It provides information about the amount of the fusion gene present in the sample.
Symptoms and Diagnosis
APL affects the bone marrow and blood, causing various symptoms. If you experience symptoms such as abnormal bleeding, frequent infections, or fatigue, it is important to consult a physician. The PML/RARA quantitative test can help diagnose APL and guide treatment decisions.
Cost and Components
The PMLRARA Quantitative Test costs AED 2310.0. It can be performed on whole blood, culture cells, bone marrow aspirations, and other sample conditions.
Report Delivery
Expect to receive your test results within the 3rd working day via email (36 hours) or phone (24 hours).
Pre Test Information
Prior to the test, you will need to sign a consent document and bring any relevant clinical history of the patient for the PML/RARA Quantitative Test.
Importance of the Test
The PML/RARA quantitative test is a valuable tool in the diagnosis and management of APL. It provides important information about the presence and quantity of the PML/RARA fusion gene, which can help guide treatment decisions and monitor the response to therapy.
Conclusion
Don’t wait to address your concerns about APL. Contact a physician today and inquire about the PMLRARA Quantitative Test offered by DNA Labs UAE. Early detection and monitoring can make a significant difference in the management of this type of leukemia.
| Test Name | PMLRARA Quantitative Test |
|---|---|
| Components | |
| Price | 2310.0 AED |
| Sample Condition | Whole Blood, Culture Cells, Bone marrow aspirations, |
| Report Delivery | 3rd Working Day Email:-36 hours. On phone: 24 hours |
| Method | Real Time PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forPML/RARA QuantitativeTest |
| Test Details |
The PML/RARA quantitative test is a laboratory test used to detect the presence of a specific genetic abnormality called the PML/RARA fusion gene. This genetic abnormality is associated with a subtype of acute promyelocytic leukemia (APL), a type of cancer that affects the bone marrow and blood. The test is typically performed on a sample of bone marrow or blood cells. It uses a technique called polymerase chain reaction (PCR) to amplify and detect the PML/RARA fusion gene. PCR is a method that allows for the rapid production of many copies of a specific DNA sequence, making it easier to detect and analyze. The PML/RARA quantitative test provides information about the amount of PML/RARA fusion gene present in the sample. This information can be used to monitor the response to treatment in patients with APL. It can also be used to detect minimal residual disease (MRD), which refers to the small number of cancer cells that may remain in the body after treatment. Monitoring MRD is important because it can help guide treatment decisions and predict the risk of relapse. If MRD levels remain high, additional treatment may be necessary to prevent the cancer from returning. Overall, the PML/RARA quantitative test is a valuable tool in the diagnosis and management of APL. It provides important information about the presence and quantity of the PML/RARA fusion gene, which can help guide treatment decisions and monitor the response to therapy. |
